Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Cardiovascular Diabetology|July 24, 2020
Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapiesMiriam Longo, Paola Caruso, Maria Ida Maiorino, et al.
Diabetes, Obesity & Metabolism|August 3, 2019
GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trialsDario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, et al.
Cardiovascular Diabetology|December 17, 2021
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTsDario Giugliano, Miriam Longo, Lorenzo Scappaticcio, et al.
Endocrine|April 28, 2019
Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trialsDario Giugliano, Maria Ida Maiorino, Miriam Longo, et al.
International Journal of Molecular Sciences|August 29, 2024
DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined ApplicationMiriam Longo, Erika Paolini, Pietro Di Benedetto, et al.
Diabetes, Obesity & Metabolism|March 12, 2021
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysisDario Giugliano, Miriam Longo, Paola Caruso, et al.
Korean Journal of Orthodontics|May 13, 2021
Complications reported with the use of orthodontic miniscrews: A systematic reviewAntonino Lo Giudice, Lorenzo Rustico, Miriam Longo, et al.
Diabetes Research and Clinical Practice|August 1, 2021
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective studyMiriam Longo, Lorenzo Scappaticcio, Maria Ida Maiorino, et al.
Frontiers in Endocrinology|March 6, 2019
Diabetes and Aging: From Treatment Goals to Pharmacologic TherapyMiriam Longo, Giuseppe Bellastella, Maria Ida Maiorino, et al.
Diabetes Research and Clinical Practice|June 26, 2019
The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trialsMaria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, et al.
Pageof 13